Why the study?
Does combined maternal digoxin and dexamethasone therapy resolve fetal hydrops in isolated complete heart block?
Does combined maternal digoxin and dexamethasone therapy resolve fetal hydrops in isolated complete heart block?
Combined maternal digoxin and dexamethasone therapy may be effective in resolving fetal hydrops associated with isolated complete heart block.
May support combined maternal therapy in select fetal heart block cases with hydrops; leaves open need for prospective confirmation.
The development of hydrops fetalis in cases of isolated complete heart block is associated with a very poor prognosis. Various pharmacological strategies have been proposed, involving both direct fetal access and transplacental therapy, with inconsistent results in small numbers of subjects. The optimal antenatal management will remain uncertain until multicentre controlled trials are organised. We report the complete resolution of fetal hydrops at 30 weeks of gestation using combination of maternal digoxin and dexamethasone therapy, despite persistence of the complete heart block. A Caesarean section was performed at 37 weeks of gestation due to evidence of fetal intrauterine growth restriction. The baby girl is now 8 months of age and remains well, with a heart rate of 45-50 beats per minute on no medication and without pacing.
No takes yet. Share an insight, caveat, or question.
Brackley et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: